Although there has been limited research into its role in the intestinal tract, TFF1 is observed to increase at sites of intestinal inflammation, such as in patients with active IBD, and in some non-intestinal inflammatory conditions, such as pancreatitis [45,46,47,48]. Here, TFF1 is linked to irritable bowel syndrome.